Company / Tangible Book Value per Share
Summit Therapeutics Inc. Tangible Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.88
FY2025
5-year range
$0.24 / $0.88
FY2021-FY2025
Trend
+59.3%
vs FY2024
Sector context
#162 of 209
Health Care
What the data says
Summit Therapeutics Inc.'s tangible book value per share of $0.88 is lower than 78% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has fluctuated over the past 7 years, ranging from $0.24 in FY2021 to $2.34 in FY2019.
Based on SEC 10-K filings.
0.88 in FY2025 with a 5-year CAGR of -5.3%.
Improved from $0.36 to $0.88 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
-99.1% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 59.3% year-over-year.
- Ranks #162 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.88 | +59.3% |
| FY2024 | $0.55 | +53.6% |
| FY2023 | $0.36 | -56.8% |
| FY2022 | $0.83 | +243.8% |
| FY2021 | $0.24 | -79.0% |
| FY2020 | $1.15 | -50.8% |
| FY2019 | $2.34 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026